Migration of cells is critical to development of the central nervous system. Reelin, which was identified from the reeler mutant mice having a defect in the multilamellar structure of the brain, is thought to be a key signalling molecule that functions as a cue for determination of cell position. mDab1 (mouse Disabled homologue 1) functions downstream of Reelin. However, the mechanism by which mDab1 regulates cell migration during brain development is unknown. In the present paper, we show that mDab1 associates with N-WASP (neuronal Wiskott–Aldrich syndrome protein) in vitro and in brains of embryonic mice. mDab1 activates N-WASP directly, and induces actin polymerization through the Arp2/3 (actin-related protein 2/3) complex. mDab1 induces formation of filopodia when it is overexpressed in COS-7 cells. This filopodium formation is dependent on N-WASP, because expression of an N-WASP mutant that cannot induce Arp2/3-complex-mediated actin polymerization suppressed filopodium formation. The PTB (phosphotyrosine-binding) domain of mDab1 binds to N-WASP via the NRFY (Asn-Arg-Phe-Tyr) sequence close to the CRIB (Cdc42/Rac-interactive binding) motif of N-WASP and activates N-WASP in vitro. When mDab1 is phosphorylated by Fyn kinase in COS-7 cells, mDab1 is ubiquitinated in a Cbl-dependent manner, and mDab1 does not induce filopodium in the presence of activated Fyn. These findings suggest that mDab1 regulates the actin cytoskeleton through N-WASP, which is negatively regulated by phosphorylation-mediated ubiquitination of mDab1.
Skip Nav Destination
Close
Article navigation
November 2004
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
November 09 2004
Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1
Shiro SUETSUGU
;
Shiro SUETSUGU
*Department of Biochemistry, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
†CREST, Japan Science and Technology Corporation (JST), 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
Search for other works by this author on:
Tohru TEZUKA
;
Tohru TEZUKA
‡Department of Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
Search for other works by this author on:
Toshifumi MORIMURA
;
Toshifumi MORIMURA
§Department of Molecular Neurobiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
∥Laboratory for Developmental Neurobiology, RIKEN Brain Science Institute, 2-1, Hirosawa, Wako, Saitama 351-0198, Japan
Search for other works by this author on:
Mitsuharu HATTORI
;
Mitsuharu HATTORI
¶Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan
**PREST, Japan Science and Technology Corporation (JST), Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan
Search for other works by this author on:
Katsuhiko MIKOSHIBA
;
Katsuhiko MIKOSHIBA
§Department of Molecular Neurobiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
∥Laboratory for Developmental Neurobiology, RIKEN Brain Science Institute, 2-1, Hirosawa, Wako, Saitama 351-0198, Japan
Search for other works by this author on:
Tadashi YAMAMOTO
;
Tadashi YAMAMOTO
‡Department of Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
Search for other works by this author on:
Tadaomi TAKENAWA
Tadaomi TAKENAWA
1
*Department of Biochemistry, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
†CREST, Japan Science and Technology Corporation (JST), 4-6-1 Shirokane-dai, Minato-ku, Tokyo, 108-8639, Japan
1To whom correspondence should be addressed (email takenawa@ims.u-tokyo.ac.jp).
Search for other works by this author on:
Biochem J (2004) 384 (1): 1–8.
Article history
Received:
June 28 2004
Revision Received:
August 23 2004
Accepted:
September 13 2004
Accepted Manuscript online:
September 13 2004
Connected Content
A commentary has been published:
Filopodia formation and Disabled degradation downstream of Reelin
Citation
Shiro SUETSUGU, Tohru TEZUKA, Toshifumi MORIMURA, Mitsuharu HATTORI, Katsuhiko MIKOSHIBA, Tadashi YAMAMOTO, Tadaomi TAKENAWA; Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem J 15 November 2004; 384 (1): 1–8. doi: https://doi.org/10.1042/BJ20041103
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Mechanisms controlling EGF receptor endocytosis and degradation
Biochem Soc Trans (December,2003)
Filopodia formation and Disabled degradation downstream of Reelin
Biochem J (November,2004)
Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl
Biochem J (February,2003)
EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate
Biochem J (February,2008)